Market Overview

Research and Markets: IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Austria

Share:
DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/7f5n4d/ims) has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Austria" report to their offering.

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Key Topics Covered:

HEALTHCARE SYSTEM

- Facts & Figures

- Market Indicators

- Provision & Funding

PRICING

- Prescription Drugs

- Generic Drugs

- Hospital Drugs

- OTC Drugs

REIMBURSEMENT

- Admission to Reimbursement

- Reimbursement Categories

- Reimbursement Prices

- Hospital Reimbursement

- Changes in Reimbursement Status

- Changes in Reimbursement Prices

PHARMACOECONOMICS

- Pharmacoeconomic Requirements

- Price Build Up

- Wholesalers Retail Pharmacies

- Dispensing Doctors

- Sales Tax

COST CONTAINMENT

- Industry Paybacks

- Promotional Costs

- Patient Co-payments

- Prescribing Controls

- Generics

- Rx-to-OTC Switches

- Parallel Trade

FUTURE DEVELOPMENTS

- Outlook

NAMES & ADDRESSES

For more information visit http://www.researchandmarkets.com/research/7f5n4d/ims

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

View Comments and Join the Discussion!